tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Income Statement

Compare
1,827 Followers

VYNE Therapeutics Income Statement

Last quarter (Q3 2024), VYNE Therapeutics's total revenue was $121.00K, an increase of 6.14% from the same quarter last year. In Q3, VYNE Therapeutics's net income was $-12.16M. See VYNE Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 424.00K$ 477.00K$ 14.76M$ 20.99M$ 443.00K
Gross Profit
$ 424.00K$ 477.00K$ 11.41M$ 19.60M$ 93.00K
Operating Expenses
$ 29.68M$ 34.77M$ 79.44M$ 133.08M$ 76.24M
Depreciation and Amortization
$ 0.00$ 72.00K$ 109.00K$ 341.00K$ 350.00K
EBITDA
$ -29.26M$ -34.22M$ -38.94M$ -251.09M$ -94.08M
Operating Income
$ -29.26M$ -34.30M$ -68.03M$ -113.47M$ -76.24M
Other Income/Expenses
$ 1.39M$ 363.00K$ -5.75M$ -142.35M$ -19.11M
Pretax Income
$ -27.87M$ -33.93M$ -73.78M$ -255.83M$ -73.70M
Net Income
$ -28.45M$ -33.95M$ -73.33M$ -255.57M$ -70.46M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.77$ -10.65$ -25.65$ -141.90$ -149.48
Diluted EPS
$ -2.77$ -10.65$ -25.65$ -141.90$ -149.48
Weighted Average Shares Outstanding
10.27M 3.19M 2.86M 1.80M 471.39K
Weighted Average Shares Outstanding (Diluted)
10.27M 3.19M 2.86M 1.80M 471.39K
Currency in USD

VYNE Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis